Irem Yilmazbilek

Irem Yilmazbilek

Auto-generated profile, based on publicly available information

Irem Yilmazbilek

Middle East Technical University (METU)

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2023 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Closed access
PDF file
DDDidem Naz Dioken
Didem Naz Dioken
IOIbrahim Ozgul
Ibrahim Ozgul
IYIrem Yilmazbilek
Irem Yilmazbilek
MYMustafa Cengiz Yakicier
Mustafa Cengiz Yakicier
EKEzgi Karaca
Ezgi Karaca
AEAYSE ERSON-BENSAN
AYSE ERSON-BENSAN

21 September 2025 in RNA Biology
Verified
Journal Article
Open access
DDDidem Naz Dioken
Didem Naz Dioken
IOIbrahim Ozgul
Ibrahim Ozgul
IYIrem Yilmazbilek
Irem Yilmazbilek
EAElanur Almeric
Elanur Almeric
IEIrem Cemile Eroglu
Irem Cemile Eroglu
AEAYSE ERSON-BENSAN
AYSE ERSON-BENSAN
Oestrogen receptor alpha (ERα)-positive (ER+) breast cancers are driven by the binding of 17β-oestradiol (E2) to ERα, which transcriptionally regulates target genes. Although microarrays and conventional RNA sequencing have identified E2 target genes, pre-designed probes and short read lengths are limited in their ability to accurately capture complex transcript structures. Long-read sequencing offers a solution by spanning entire transcripts, providing a more complete view of the transcriptome. Here, we employed nanopore long-read direct RNA sequencing (DRS) complemented with 3'-end sequencing, in vitro experiments, and deep learning-based protein modelling to explore the landscape of the E2-responsive transcriptome and protein level implications. Our analysis revealed a range of E2-responsive non-coding and coding isoforms, including intronically polyadenylated (IPA) mRNAs. One of these IPA isoforms was detected for TLE1, which assists ERα-chromatin interactions for a subset of E2 targets. The IPA isoform produces a C-terminus truncated protein that lacks the WDR interaction domain but retains dimerization/tetramerization capacity through its intact N-terminal Q-domain. Structural modelling and protein-based assays confirmed the dimerization potential and nuclear localization of the truncated protein. Functional assays showed that the overexpression of truncated TLE1 reduced the E2-induced upregulation of TFF1 and GREB1, E2-responsive genes, thereby disrupting transcriptional regulation. Importantly, a lower IPA isoform ratio is associated with worse survival in ER+ breast cancers, highlighting clinical relevance. Our study revealed new layers of complexity in the E2-regulated transcriptome, providing insights into truncated proteins. These findings contribute to a deeper understanding of gene regulation and may help the development of new therapeutic strategies.

11 October 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
BSBüşra Savaş
Büşra Savaş
IYİrem Yılmazbilek
İrem Yılmazbilek
AÖAtakan Özsan
Atakan Özsan
EKEzgi Karaca
Ezgi Karaca
In the 55 th round of CAPRI, we used enhanced AlphaFold2 (AF2) sampling and data-driven docking. Our AF2 protocol relies on Wallner’s massive sampling approach, which combines different AF2 versions and sampling parameters to produce thousands of models per target. For T231 (an antibody peptide complex) and T232 (PP2A:TIPRL complex), we employed a 50-fold reduced MinnieFold sampling and a custom ranking approach, leading to a top-ranking medium prediction in both cases. For T233 and T234 (two antibody bound MHC I complexes), we followed data-driven docking, which did not lead to an acceptable model. Our post-CAPRI55 analysis showed that if we would have used our MinnieFold approach on T233 and T234, we could have submitted a medium-quality model for T233 as well. In the scoring challenge, we utilized the scoring function of FoldX, which was effective in selecting acceptable models for T231 and medium quality models for T232. Our success, especially in predicting and ranking a medium quality model for T231 and potentially for T233 underscores the feasibility of green and accurate enhanced AF2 sampling in antibody complex prediction.

2 August 2025 in bioRxiv
Verified
Preprint
Open access
DDDidem Naz Dioken
Didem Naz Dioken
IOIbrahim Ozgul
Ibrahim Ozgul
IYIrem Yilmazbilek
Irem Yilmazbilek
EAElanur Almeric
Elanur Almeric
IEIrem Cemile Eroglu
Irem Cemile Eroglu
AEAYSE ERSON-BENSAN
AYSE ERSON-BENSAN
Estrogen receptor alpha (ERα)-positive (ER+) breast cancers are driven by 17β-estradiol (E2) binding to ERα, which transcriptionally regulates downstream target genes. Although microarrays and conventional RNA sequencing have identified E2 target genes, pre-designed probes and short read lengths are limited in accurately capturing complex transcript structures. Long-read RNA sequencing offers a solution by spanning entire transcripts, providing a more complete view of the transcriptome. Here, we employed nanopore long-read direct RNA sequencing (DRS) complemented with 3’-end sequencing, in vitro experiments, and deep learning-based protein modeling to explore the intricate landscape of E2-responsive transcriptome and protein level implications. Our analysis revealed a range of E2-responsive non-coding and coding isoforms, including intronically polyadenylated (IPA) mRNAs. One of these IPA isoforms was detected for TLE1 (Transducin-like enhancer protein 1), which positively assists ERα-chromatin interactions for a subset of E2 target genes. The IPA isoform produces a C-terminus truncated protein, lacking the WDR interaction domain, but retains dimerization/tetramerization capacity through its intact N-terminus Q-domain. Structural modeling and protein-based assays confirmed the truncated protein’s dimerization potential and nuclear localization. Functional assays showed that overexpression of truncated TLE1 reduces the E2-induced upregulation of GREB1 , an E2-responsive gene, thereby disrupting transcriptional regulation. Importantly, a lower IPA isoform ratio is associated with worse survival in ER+ patients, highlighting clinical relevance. Our study uncovers new layers of complexity in the E2-regulated transcriptome, providing insights into truncated proteins. These findings contribute to a deeper understanding of gene regulation and may help the development of new therapeutic strategies.